Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse Roman

Showing results (61-70 of 214) with videos related to

Pageof 22
Sort By:
The American Journal of the Medical Sciences|May 27, 2011
Management of idiopathic pulmonary fibrosisDaniel Fioret, Rafael L Perez, Jesse Roman
Cancer Research|January 7, 2006
Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathwaysShouWei Han, Fadlo R Khuri, Jesse Roman
Methods in Molecular Biology (Clifton, N.J.)|April 7, 2009
PPARbeta/delta agonist increases the expression of PGE2 receptor subtype EP4 in human lung carcinoma cellsJeffrey D Ritzenthaler, Jesse Roman, ShouWei Han
Cancer Therapy|December 17, 2008
Thiazolidinediones as anti-cancer agentsCarmelo Blanquicett, Jesse Roman, C Michael Hart
American Journal of Respiratory Cell and Molecular Biology|January 29, 2005
Peroxisome proliferator-activated receptor-gamma ligands inhibit alpha5 integrin gene transcription in non-small cell lung carcinoma cellsShouWei Han, Hilda N Rivera, Jesse Roman
Molecular Biosystems|April 28, 2009
Stimulation of lung carcinoma cell growth by fibronectin-integrin signallingJeffrey D Ritzenthaler, Shouwei Han, Jesse Roman
Respiratory Research|November 21, 2018
Role of SOD3 in silica-related lung fibrosis and pulmonary vascular remodelingIgor N Zelko, Jianxin Zhu, Jesse Roman
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 17, 2002
Regulation of serum-induced fibronectin expression by protein kinases, cytoskeletal integrity, and CREBJeffrey E Michaelson, Jeffrey D Ritzenthaler, Jesse Roman
Clinical Transplantation|September 13, 2021
Donor factors and risk of primary graft dysfunction and mortality post lung transplantation: A proposed conceptual frameworkMrinalini Venkata-Subramani, David R Nunley, Jesse Roman
Annals of the American Thoracic Society|October 24, 2025
High Flow Oxygen Therapy in ILD Exacerbations: An Imperfect TherapyKathleen Spritzer, Jesse Roman, Ross Summer, et al.
Pageof 22

Showing results (61-70 of 214) with videos related to

Sort By:
Pageof 22
The American Journal of the Medical Sciences|May 27, 2011
Management of idiopathic pulmonary fibrosisDaniel Fioret, Rafael L Perez, Jesse Roman
Cancer Research|January 7, 2006
Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathwaysShouWei Han, Fadlo R Khuri, Jesse Roman
Methods in Molecular Biology (Clifton, N.J.)|April 7, 2009
PPARbeta/delta agonist increases the expression of PGE2 receptor subtype EP4 in human lung carcinoma cellsJeffrey D Ritzenthaler, Jesse Roman, ShouWei Han
Cancer Therapy|December 17, 2008
Thiazolidinediones as anti-cancer agentsCarmelo Blanquicett, Jesse Roman, C Michael Hart
American Journal of Respiratory Cell and Molecular Biology|January 29, 2005
Peroxisome proliferator-activated receptor-gamma ligands inhibit alpha5 integrin gene transcription in non-small cell lung carcinoma cellsShouWei Han, Hilda N Rivera, Jesse Roman
Molecular Biosystems|April 28, 2009
Stimulation of lung carcinoma cell growth by fibronectin-integrin signallingJeffrey D Ritzenthaler, Shouwei Han, Jesse Roman
Respiratory Research|November 21, 2018
Role of SOD3 in silica-related lung fibrosis and pulmonary vascular remodelingIgor N Zelko, Jianxin Zhu, Jesse Roman
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 17, 2002
Regulation of serum-induced fibronectin expression by protein kinases, cytoskeletal integrity, and CREBJeffrey E Michaelson, Jeffrey D Ritzenthaler, Jesse Roman
Clinical Transplantation|September 13, 2021
Donor factors and risk of primary graft dysfunction and mortality post lung transplantation: A proposed conceptual frameworkMrinalini Venkata-Subramani, David R Nunley, Jesse Roman
Annals of the American Thoracic Society|October 24, 2025
High Flow Oxygen Therapy in ILD Exacerbations: An Imperfect TherapyKathleen Spritzer, Jesse Roman, Ross Summer, et al.
Pageof 22